Method of determining metastatic potential of bladder tumor cells
US5650500A · kind A · utility
12Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 1994 |
| Grant date | Jul 22, 1997 |
| Priority date | — |
| Expiry date | Jul 27, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods and compositions useful in the detection of human cancer cells and malignant tumors are provided. Certain human autocrine motility factor receptors or proteins (gp78-hAMFR) have been identified which are useful in the detection of human cancer cells and malignant tumors. Methods and assay kits for the detection of human cancer, human cancer cells, and tumors, are provided wherein antibodies or nucleotide hybridized probes are used to determine gp78-hAMFR expression. These methods and assays readily distinguish between non-malignant and malignant cancer cells and tumors and can be used to gauge metastatic potential.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.